Literature DB >> 25241092

Infantile and congenital hemangiomas.

Marilyn G Liang1, Ilona J Frieden2.   

Abstract

Infantile hemangiomas (IHs) are the most common benign vascular tumors of infancy. Since they predominantly involute without significant residua, the majority do not require treatment. Indications for intervention include ulceration, prevention of disfigurement, and impairment of function or vital structures. Some IHs have associated structural anomalies. When and which IH to treat requires knowledge of the natural history and clinical findings of increased risk. Congenital hemangiomas (CHs) are fully formed at birth. They also differ from IHs in their histological and immunohistochemical findings and thus represent a distinct clinical entity. Their clinical characteristics and management are also discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital hemangioma; Infantile hemangioma; LUMBAR; PELVIS; PHACE; Propranolol

Mesh:

Year:  2014        PMID: 25241092     DOI: 10.1053/j.sempedsurg.2014.06.017

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  10 in total

Review 1.  Tracheal and bronchial tumors.

Authors:  Patricio Varela; Luca Pio; Elisa Brandigi; Irene Paraboschi; Nazhia Khen-Dunlop; Erik Hervieux; Cecile Muller; Girolamo Mattioli; Sabine Sarnacki; Michele Torre
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Les anomalies vasculaires pendant l'enfance : quand traiter les patients et quand les diriger vers une ressource spécialisée.

Authors:  Kelley Zwicker; Julie Powell; Carl Cummings
Journal:  Paediatr Child Health       Date:  2022-08-22       Impact factor: 2.600

3.  Vascular anomalies in childhood: When to treat and when to refer.

Authors:  Kelley Zwicker; Julie Powell; Carl Cummings
Journal:  Paediatr Child Health       Date:  2022-08-22       Impact factor: 2.600

4.  Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.

Authors:  Bingqing Liang; Yunyun Zhan; Xiangxin Huang; Ermin Gu; Dapeng Dai; Jianping Cai; Guoxin Hu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

Review 5.  Interventions for infantile haemangiomas of the skin.

Authors:  Monica Novoa; Eulalia Baselga; Sandra Beltran; Lucia Giraldo; Ali Shahbaz; Hector Pardo-Hernandez; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

6.  Acquired sessile conjunctival capillary haemangioma in an adult managed with topical timolol.

Authors:  Deepsekhar Das; Sandton Jayakumari Simon Raj; Mandeep S Bajaj
Journal:  BMJ Case Rep       Date:  2020-08-24

7.  Different Clinical Features of Acral Abortive Hemangiomas.

Authors:  N Vega Mata; J C López Gutiérrez; B Vivanco Allende; M S Fernández García
Journal:  Case Rep Dermatol Med       Date:  2017-07-12

8.  Rapidly Involuting Congenital Hemangioma of the Hand.

Authors:  Daniel Delgadillo; Logan W Carr; Morgan S Brgoch; John M Ingraham
Journal:  Eplasty       Date:  2017-03-08

9.  MicroRNA Microarray Profiling in Infantile Hemangiomas.

Authors:  Brent Earl Schultz; Christopher R Spock; Laura K Tom; Yong Kong; Karina T Canadas; Samuel Kim; Milton Waner; Teresa O; Richard Antaya; Deepak Narayan
Journal:  Eplasty       Date:  2019-04-16

Review 10.  Childhood Vascular Tumors.

Authors:  Harriet Bagnal Hinen; Cameron C Trenor; Lara Wine Lee
Journal:  Front Pediatr       Date:  2020-10-22       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.